Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era

Affiliations

• ¹ Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• ² Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• ³ Department of Medicine, Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• ⁴ Edward S. Harkness Eye Institute, Department of Ophthalmology, Columbia University Irving Medical Center - New York-Presbyterian Hospital, New York, New York, USA.
• ⁵ Department of Radiology, Nuclear Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• ⁶ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.